Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CRSP
CRISPR Therapeutics AG
Last Price:
$53.51
Seasonality Move:
1.96%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.27 | Buy |
| 20-day SMA: | 52.03 | Buy |
| 50-day SMA: | 54.25 | Buy |
| 200-day SMA: | 54.05 | Buy |
| 8-day EMA: | 50.91 | Buy |
| 20-day EMA: | 39.8 | Buy |
| 50-day EMA: | 22.98 | Buy |
| 200-day EMA: | 7.08 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.41 | Buy |
| Relative Strength Index (14 RSI): | 55.41 | Buy |
| Chaikin Money Flow: | 940443 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.37 - 55.63) | Buy |
| Bollinger Bands (100): | (50.88 - 64.9) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 54.64 while CRSP 8-day simple moving average is 51.27, which is a Buy signal.
-
The stock price of CRSP is 54.64 while CRISPR Therapeutics AG 20-day SMA is 52.03, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 54.25 while CRSP share price is 54.64, making it a Buy technically.
-
CRSP stock price is 54.64 and CRISPR Therapeutics AG 200-day simple moving average is 54.05, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
62
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a BuyThe current CRISPR Therapeutics AG [CRSP] share price is $54.64. The Score for CRSP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.2B
Price in USD:
54.64
Share Volume:
984.2K
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Buy
62
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 54.64 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 54.64 while CRSP 8-day exponential moving average is 50.91, which is a Buy signal.
-
The stock price of CRSP is 54.64 while CRISPR Therapeutics AG 20-day EMA is 39.80, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 22.98 while CRSP share price is 54.64, making it a Buy technically.
-
CRSP stock price is 54.64 and CRISPR Therapeutics AG 200-day simple moving average is 7.08, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.22 per share, an increase this year of $1.23 per share, and an increase next year of $0.78 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 12.41, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 55.41, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (49.37 - 55.63), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (50.88 - 64.9), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.